North America Hyperphosphatemia Drug Market Forecast 2019-2027

Publisher Name :
Date: 19-Nov-2018
No. of pages: 80

Key Findings

The North America hyperphosphatemia drug market is expected to grow at a CAGR of 15.19% over the forecast period. The region is expected to hold the largest share in the market with an anticipated increase in the revenue from $xx million in 2018 to $xx million by 2027. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. Increasing prevalence of these chronic diseases along with unattended medical needs are driving the hyperphosphatemia drug market in this region.

Market Insights

The changing dietary patterns along with the increasing cases of osteoporosis diseases in countries like the United States and Canada are providing the hyperphosphatemia drug market with plenty of growth opportunities. The market is mainly categorized by the different types of drug binders such as iron-based phosphate binders, magnesium-based phosphate binders, aluminium-based phosphate binders, calcium-based phosphate binders and others. The aluminium-based phosphate binders generated revenue of $203 million in 2016 and are widely used with magnesium-based phosphate binders for treating patients on dialysis. However, it is the calcium-based phosphate binders that held the largest market share of xx% in 2018 and are expected to continue their dominance throughout the forecasted period. Despite such phenomenal growth, the market is facing some tough challenges due to the various limitations imposed by the Food and Drug Administration (FDA) and the rising side effects observed due to the use of some of the hyperphosphatemia drugs.

Competitive Insights

Some of the eminent companies in the hyperphosphatemia drug market include Royal Dsm, Amag, Sun Pharma, and Keryx. Other top players in the market are Zeria Pharmaceutical, Johnson and Johnson, Bruno Pharmaceutical Spa, Cipla, Ultragenyx, Fresenius Medical Care, Roche Diagnostics Corporation, R.H. Moore Drug Co., Sanofi, Fermenta Biotech Ltd, Vifor Pharma, Shire and Pfizer Inc.

North America Hyperphosphatemia Drug Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Iron-Based Hyperphosphatemia Drugs Is A Game Changer
4. Market Determinants
4.1. Market Scope & Definition
4.2. Drivers
4.2.1. Growing Prevalence of Chronic Diseases
4.2.2. Unmet Medical Needs
4.2.3. Skewed Population Mix Towards Elderly People
4.2.4. Rise In Public Awareness
4.3. Restraints
4.3.1. Limitations Levied By The Food And Drug Administration (Fda)
4.3.2. Growing Side Effects of The Hyperphosphatemia Drugs
4.4. Challenges
4.4.1. Non-Adherence To Treatment Regimens
4.4.2. Side Effects of Drugs
4.4.3. Limited Availability of Drugs
4.4.4. Use of Advanced Dialysis Techniques
4.5. Market By Dosage
4.5.1. Solid
4.5.1.1. Tablet
4.5.1.2. Powder
4.5.2. Liquid
4.5.2.1. Solution
5. Market By Formulation
5.1.1. Calcium-Based Phosphate Binders
5.1.2. Aluminum-Based Phosphate Binders
5.1.3. Magnesium-Based Phosphate Binders
5.1.4. Iron-Based Phosphate Binders
5.1.5. Other Phosphate Binders
6. Key Analytics
6.1. Porter's Five Force Model
6.1.1. Threat of New Entrants
6.1.2. Bargaining Power of Buyers
6.1.3. Bargaining Power of Suppliers
6.1.4. Threat of Substitute Product
6.1.5. Intensity of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Application
6.3.2. Pricing
6.3.3. Effectiveness
6.3.4. Availability
6.4. Strategic Recommendation & Strategic Conclusions
6.5. Market Trends
6.5.1. Patient Assistance Programs
6.5.2. Strategic Alliances
6.5.3. Increase In R&D
6.6. Phosphate Binders Usages Guidelines
7. Geographic Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Amag Pharmaceuticals
8.2.1.1. Overview
8.2.1.2. Product Portfolio
8.2.1.3. Scot Analysis
8.2.1.4. Strategic Initiatives
8.2.2. Biotech Pharmacal
8.2.2.1. Overview
8.2.2.2. Products Portfolio
8.2.2.3. Scot Analysis
8.2.2.4. Strategic Initiatives
8.2.3. Bruno Farmaceutici Spa
8.2.3.1. Overview
8.2.3.2. Product Portfolio
8.2.3.3. Scot Analysis
8.2.3.4. Strategic Initiatives
8.2.4. Cipla
8.2.4.1. Overview
8.2.4.2. Product Portfolio
8.2.4.3. Scot Analysis
8.2.4.4. Strategic Initiatives
8.2.5. Fermenta Biotech Ltd
8.2.5.1. Overview
8.2.5.2. Product Portfolio
8.2.5.3. Scot Analysis
8.2.5.4. Strategic Initiatives
8.2.6. Fresenius Medical Care
8.2.6.1. Overview
8.2.6.2. Product Portfolio
8.2.6.3. Scot Analysis
8.2.6.4. Strategic Initiatives
8.2.7. Johnson And Johnson
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Scot Analysis
8.2.7.4. Strategic Initiatives
8.2.8. Keryx Biopharmaceuticals Inc
8.2.8.1. Overview
8.2.8.2. Scot Analysis
8.2.8.3. Strategic Initiatives
8.2.9. Pfizer Inc.
8.2.9.1. Overview
8.2.9.2. Product Portfolio
8.2.9.3. Scot Analysis
8.2.9.4. Strategic Initiatives
8.2.10. Roche Diagnostics Corporation
8.2.10.1. Overview
8.2.10.2. Product Portfolio
8.2.10.3. Scot Analysis
8.2.10.4. Strategic Initiatives
8.2.11. Royal Dsm N.V.
8.2.11.1. Overview
8.2.11.2. Product Portfolio
8.2.11.3. Scot Analysis
8.2.11.4. Strategic Initiatives
8.2.12. Sanofi
8.2.12.1. Overview
8.2.12.2. Product Portfolio
8.2.12.3. Scot Analysis
8.2.12.4. Strategic Initiatives
8.2.13. Shire
8.2.13.1. Overview
8.2.13.2. Product Portfolio
8.2.13.3. Scot Analysis
8.2.13.4. Strategic Initiatives
8.2.14. Sun Pharmaceutical Industries Ltd
8.2.14.1. Overview
8.2.14.2. Products Portfolio
8.2.14.3. Scot Analysis
8.2.14.4. Strategic Initiatives
8.2.15. Ultragenyx Pharmaceutical Inc.
8.2.15.1. Overview
8.2.15.2. Product Portfolio
8.2.15.3. Scot Analysis
8.2.15.4. Strategic Initiatives
8.2.16. Zeria Pharmaceutical
8.2.16.1. Overview
8.2.16.2. Product Portfolio
8.2.16.3. Scot Analysis
8.2.16.4. Strategic Initiatives

List of Tables

Table 1 North America Hyperphosphatemia Drug Market 2019-2027($ Million)
Table 2 Iron-Based Hyperphosphatemia Drug Approval Status 2014-2017
Table 3 Worldwide Population Aged 80 And Above 1950-2050 (Millions)
Table 4 Phosphorous Levels In Select Foods
Table 5 North America Hyperphosphatemia Drugs Market By Formulation 2019-2027($ Million)
Table 6 North America Calcium-Based Phosphate Binders 2019-2027($ Million)
Table 7 North America Aluminum-Based Phosphate Binders 2019-2027($ Million)
Table 8 North America Magnesium-Based Phosphate Binders 2019-2027($ Million)
Table 9 North America Iron-Based Phosphate Binders 2019-2027($ Million)
Table 10 North America Other Phosphate Binders 2019-2027($ Million)
Table 11 Pipeline Portfolio of Hyperphosphatemia Drugs
Table 12 North America Hyperphosphatemia Drugs Market 2019-2027 ($ Million)
Table 13 North America Hyperphosphatemia Drugs Market By Country 2019-2027($ Million)

List of Figures

Figure 1 Rate of Adherence To Phosphate Binders
Figure 2 Diagnosis And Clinical Indicators of Chronic Kidney Disease
Figure 3 North America Hyperphosphatemia Drugs Market By Calcium-Based Phosphate Binders 2019-2027($ Million)
Figure 4 North America Hyperphosphatemia Drugs Market By Aluminum-Based Phosphate Binders 2019-2027($ Million)
Figure 5 North America Hyperphosphatemia Drugs Market By Magnesium-Based Phosphate Binders 2019-2027($ Million)
Figure 6 North America Hyperphosphatemia Drugs Market By Iron-Based Phosphate Binders 2019-2027($ Million)
Figure 7 North America Hyperphosphatemia Drugs Market By Other Phosphate Binders 2019-2027($ Million)
Figure 8 Porters 5 Force Model of Hyperphosphatemia Market
Figure 9 North America Hyperphosphatemia Drugs Market Share, 2019 & 2027 (%)
Figure 10 North America Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 11 The United States Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 12 Canada Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 13 Market Share Analysis of Key Players 2017 (%)
  • Pompe Disease - Market Insights, Epidemiology and Market Forecast-2028
    Published: 15-Jul-2019        Price: US 9500 Onwards        Pages: 123
    DelveInsight's ‘Pompe Disease - Market Insights, Epidemiology and Market Forecast-2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the emerging market trends of Pompe Disease in the Asia (China and Taiwan), Middle East (Saudi Arabia and U.A.E.), Eastern Europe (Russia and Turkey) and LATAM (Mexico, Brazil, Argentina and Colombia). This Report provides the current treatment practices, emerging drugs, market share of the......
  • Global Head Lice Infestation Drug Market Research Report 2012-2024
    Published: 14-Jul-2019        Price: US 2050 Onwards        Pages: 78
    Summary Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. The global Head Lice Infestation Drug market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, ......
  • Global Furosemide Market Research Report 2012-2024
    Published: 13-Jul-2019        Price: US 3760 Onwards        Pages: 100
    Summary The global Furosemide market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Global Fosfomycin Trometamol Market Research Report 2012-2024
    Published: 13-Jul-2019        Price: US 1800 Onwards        Pages: 86
    Summary Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform. Mainly for the treatment of urinary tract infections such as cystitis, urethritis. The global Fosfomycin Trometamol market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis o......
  • Global Flu Vaccine Market Research Report 2012-2024
    Published: 12-Jul-2019        Price: US 1910 Onwards        Pages: 85
    Summary Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. The global Flu ......
  • Global Salmon Calcitonin Market Insights, Forecast to 2025
    Published: 12-Jul-2019        Price: US 3900 Onwards        Pages: 113
    The global Salmon Calcitonin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Salmon Calcitonin market based on company, product type, end user and key regions. This report studies the global market size of Salmon Calcitonin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle ......
  • Global Neutropenia Treatment Market Size, Status and Forecast 2019-2025
    Published: 12-Jul-2019        Price: US 3900 Onwards        Pages: 98
    Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible to infections and may even prove fatal. Therefore, the condition requires immediate prophylaxis. Novel therapies combined ......
  • Global Atropine Industry Market Research Report
    Published: 11-Jul-2019        Price: US 2960 Onwards        Pages: 135
    The Atropine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Atropine industrial chain, this report mainly elaborates the definition, types, applications and major players of Atropine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019-2024)......
  • Global Subcutaneous Immunoglobulins Industry Market Research Report
    Published: 11-Jul-2019        Price: US 2960 Onwards        Pages: 114
    The Subcutaneous Immunoglobulins market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Subcutaneous Immunoglobulins industrial chain, this report mainly elaborates the definition, types, applications and major players of Subcutaneous Immunoglobulins market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs